For the full analysisinclusive of demographics, comorbidities, and social drivers of health data for the population, methodology, additional findings, limitations, and citationsyou can view the complete report on MedRxiv or directly within Truveta Studio
Regulation of GPR119 receptor activity with endocannabinoid-like lipids
Body-weight change of 16.94% with continued trend beyond 36 weeks
It is a once-weekly investigational triple agonist designed to activate three metabolic receptor pathways at the same time: GLP-1, GIP, and glucagon
That is, when we prescribe a GLP1 receptor agonist, we might be helping our patient not just lose weight, we might also be deploying a highly potent, multi-targeted anti-inflammatory neuroprotective agent that might as well address the foundational pathophysiology of mood and psychotic disorders
Practicing mindful eating can help you better recognize and honor your body's fullness signals